Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis
1 other identifier
interventional
304
1 country
1
Brief Summary
Acute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary decompression with markedly less morbidity and mortality compared with surgery, regardless of clinical drainage. Percutaneous trans hepatic drainage (PTBD) can be alternative to endoscopic drainage in selected group especially advanced hilar strictures and patients who are unfit for endoscopic procedure. Recent ASGE guidelines suggested the performance of ERCP within 48 hours for patients with acute cholangitis; however it is conditional recommendation with very low quality of evidence. Till date, no randomized trial has compared urgent ERCP versus early ERCP for acute cholangitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedFirst Posted
Study publicly available on registry
June 27, 2023
CompletedStudy Start
First participant enrolled
June 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2024
CompletedOctober 2, 2025
July 1, 2023
12 months
May 23, 2023
September 27, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
To perform a single-centre, randomized trial comparing the efficacy (the ability to produce a desired or intended result) of urgent versus early ERCP (Endoscopic retrograde cholangiopancreatography) for reducing the risk of 30 days of mortality.
Two Years
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
PRIMARY OUTCOME: 30 day mortality
Two Years
Secondary Outcomes (1)
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
Two Years
Study Arms (2)
Urgent ERCP
EXPERIMENTALUrgent ERCP (\<24 Hours).
Early ERCP
EXPERIMENTALEarly ERCP(24 to 48 Hours).
Interventions
Eligibility Criteria
You may qualify if:
- Patients who met criteria for a definite diagnosis acute cholangitis.
You may not qualify if:
- Patients with severe acute cholangitis at admission.
- Age \< 18 years.
- Pregnancy.
- Associated Acute Severe Pancreatitis.
- Patients with suspected high grade (Bismuth III/IV) biliary stricture in whom PTBD is considered as primary method of biliary drainage.
- Not giving consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AIG Hospitals
Hyderabad, Telangana, 500032, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2023
First Posted
June 27, 2023
Study Start
June 30, 2023
Primary Completion
June 10, 2024
Study Completion
July 10, 2024
Last Updated
October 2, 2025
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share